BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Earnings

  Novavax Sales Jump 600% YoY as COVID-19 Vaccine Still in Limbo at FDA

  After more than a month of speculation over how the FDA will rule on Novavax’s application for an updated formulation of its COVID-19 shot, CEO John Jacobs said on the company’s Q1 earnings call: “When we have it, we’ll have it. Until then, we don’t have it.”

  May 8, 2025

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Job Trends

  2025 Q1 Job Market Report: Quarterly Job Postings Live Declined as Applications Spiked

  Year-over-year BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the first quarter of 2025.

  May 8, 2025

   · 

  3 min read

   · 

  Angela Gabriel
• Press Releases

  Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by the U.S. FDA

  May 8, 2025

   · 

  5 min read
• Press Releases

  Apertura Gene Therapy Showcases the Progress of its Novel Human Transferrin Receptor AAV Capsid, TfR1 CapX, and Preclinical Programs for Tuberous Sclerosis Complex (TSC) at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

  May 8, 2025

   · 

  5 min read
• Press Releases

  Eupraxia Pharmaceuticals to Host Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE) on May 9, 2025

  May 8, 2025

   · 

  9 min read
• Press Releases

  Oncocyte to Release First Quarter 2025 Results on May 12, 2025

  May 8, 2025

   · 

  1 min read
• Press Releases

  Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update

  May 8, 2025

   · 

  17 min read
• Press Releases

  Bulletin from the Annual General Meeting in Ascelia Pharma AB on 7 May 2025

  May 8, 2025

   · 

  5 min read
• Press Releases

  Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease

  May 8, 2025

   · 

  3 min read
• Press Releases

  Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

  May 8, 2025

   · 

  6 min read